LAUREN DAVIS: Open Payments
NPI 1740614015 · HELENA, MT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$708 in 34 payments from 13 companies in 2025. Trend: 2023 $460 · 2024 $921 · 2025 $708
Food & beverage: $708
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $235 |
| AstraZeneca Pharmaceuticals LP | 1 | $139 |
| Exact Sciences Corporation | 3 | $70 |
| Amgen Inc. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| PFIZER INC. | 2 | $32 |
| Novo Nordisk Inc | 1 | $28 |
| Abbott Laboratories | 1 | $24 |
| Astellas Pharma US Inc | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: VRAYLAR, BEVESPI AEROSPHERE, UBRELVY, REXULTI, The Cologuard Plus Collection Kit, NURTEC ODT, EVENITY, AMPLATZER AMULET.
Industry payments across MT — which companies pay providers there.
